CNT Group Past Earnings Performance

Past criteria checks 0/6

CNT Group's earnings have been declining at an average annual rate of -43.7%, while the Chemicals industry saw earnings growing at 7.2% annually. Revenues have been declining at an average rate of 10.9% per year.

Key information

-43.7%

Earnings growth rate

-43.7%

EPS growth rate

Chemicals Industry Growth10.2%
Revenue growth rate-10.9%
Return on equity-6.8%
Net Margin-19.7%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Calculating The Intrinsic Value Of CNT Group Limited (HKG:701)

Nov 19
Calculating The Intrinsic Value Of CNT Group Limited (HKG:701)

CNT Group Limited's (HKG:701) Shares May Have Run Too Fast Too Soon

May 27
CNT Group Limited's (HKG:701) Shares May Have Run Too Fast Too Soon

Is CNT Group (HKG:701) Using Debt Sensibly?

Oct 05
Is CNT Group (HKG:701) Using Debt Sensibly?

Is CNT Group (HKG:701) Using Debt Sensibly?

May 10
Is CNT Group (HKG:701) Using Debt Sensibly?

CNT Group (HKG:701) Has A Pretty Healthy Balance Sheet

Jun 23
CNT Group (HKG:701) Has A Pretty Healthy Balance Sheet

Non Executive Director Ho Chuen Tsui Just Bought A Handful Of Shares In CNT Group Limited (HKG:701)

Feb 03
Non Executive Director Ho Chuen Tsui Just Bought A Handful Of Shares In CNT Group Limited (HKG:701)

The Non Executive Director of CNT Group Limited (HKG:701), Ho Chuen Tsui, Just Bought A Few More Shares

Jan 09
The Non Executive Director of CNT Group Limited (HKG:701), Ho Chuen Tsui, Just Bought A Few More Shares

Does CNT Group (HKG:701) Have A Healthy Balance Sheet?

Dec 16
Does CNT Group (HKG:701) Have A Healthy Balance Sheet?

Revenue & Expenses Breakdown

How CNT Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:701 Revenue, expenses and earnings (HKD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 24400-791570
31 Mar 24448-741650
31 Dec 23496-691730
30 Sep 23548-601930
30 Jun 23600-512120
31 Mar 23633-732250
31 Dec 22666-942380
30 Sep 22720-832370
30 Jun 22775-712350
31 Mar 22830-462370
31 Dec 21885-212390
30 Sep 21903-242440
30 Jun 21920-262490
31 Mar 21851-602410
31 Dec 20782-942340
30 Sep 20759-1812360
30 Jun 20737-2692390
31 Mar 20772-172580
31 Dec 198082352770
30 Sep 198513182920
30 Jun 198944013070
31 Mar 198631883070
31 Dec 18832-253060
30 Sep 18935133080
30 Jun 181,039513090
31 Mar 181,133443080
31 Dec 171,228383060
30 Sep 171,208483000
30 Jun 171,188582950
31 Mar 171,176732900
31 Dec 161,165882850
30 Sep 161,116922730
30 Jun 161,067962600
31 Mar 161,085912620
31 Dec 151,103862640
30 Sep 151,2261012780
30 Jun 151,3491152910
31 Mar 151,4111322860
31 Dec 141,4731492800
30 Sep 141,4471712660
30 Jun 141,4221942520
31 Mar 141,4371782530
31 Dec 131,4531632530

Quality Earnings: 701 is currently unprofitable.

Growing Profit Margin: 701 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 701 is unprofitable, and losses have increased over the past 5 years at a rate of 43.7% per year.

Accelerating Growth: Unable to compare 701's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 701 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-29.6%).


Return on Equity

High ROE: 701 has a negative Return on Equity (-6.82%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies